4//SEC Filing
von Moltke Lisa 4
Accession 0000950170-25-017911
CIK 0001609809other
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 4:15 PM ET
Size
5.4 KB
Accession
0000950170-25-017911
Insider Transaction Report
Form 4
von Moltke Lisa
See Remarks
Transactions
- Award
Stock Option (Right to Buy)
2025-02-07+650,000→ 650,000 totalExercise: $0.78Exp: 2035-02-06→ Common Stock (650,000 underlying)
Footnotes (1)
- [F1]The option will vest as to 25% of the shares on February 7, 2026. The remainder of the shares will vest in 12 equal quarterly installments thereafter.
Documents
Issuer
Seres Therapeutics, Inc.
CIK 0001609809
Entity typeother
Related Parties
1- filerCIK 0001808592
Filing Metadata
- Form type
- 4
- Filed
- Feb 10, 7:00 PM ET
- Accepted
- Feb 11, 4:15 PM ET
- Size
- 5.4 KB